A detailed history of Legal & General Group PLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 143,085 shares of AMRX stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
143,085
Previous 115,425 23.96%
Holding current value
$1.17 Million
Previous $699,000 29.9%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.36 - $7.11 $148,257 - $196,662
27,660 Added 23.96%
143,085 $908,000
Q1 2024

May 14, 2024

BUY
$5.24 - $6.34 $151,954 - $183,853
28,999 Added 33.55%
115,425 $699,000
Q4 2023

Feb 15, 2024

BUY
$3.36 - $6.21 $255,776 - $472,730
76,124 Added 738.92%
86,426 $524,000
Q3 2023

Nov 14, 2023

SELL
$2.76 - $4.59 $3,552 - $5,907
-1,287 Reduced 11.11%
10,302 $43,000
Q2 2023

Aug 14, 2023

SELL
$1.33 - $3.1 $12,507 - $29,152
-9,404 Reduced 44.8%
11,589 $35,000
Q1 2023

May 15, 2023

SELL
$1.27 - $2.7 $28,602 - $60,809
-22,522 Reduced 51.76%
20,993 $29,000
Q4 2022

Feb 14, 2023

BUY
$1.96 - $2.61 $6,971 - $9,283
3,557 Added 8.9%
43,515 $86,000
Q3 2022

Nov 14, 2022

BUY
$2.02 - $3.62 $3,086 - $5,531
1,528 Added 3.98%
39,958 $81,000
Q2 2022

Aug 22, 2022

SELL
$3.01 - $4.46 $1,778 - $2,635
-591 Reduced 1.51%
38,430 $122,000
Q1 2022

May 16, 2022

SELL
$3.9 - $4.89 $244,186 - $306,172
-62,612 Reduced 61.61%
39,021 $163,000
Q3 2021

Nov 15, 2021

BUY
$4.31 - $5.64 $80,571 - $105,434
18,694 Added 22.54%
101,633 $543,000
Q1 2021

May 17, 2021

BUY
$4.74 - $7.38 $1,730 - $2,693
365 Added 0.44%
82,939 $559,000
Q4 2020

Feb 12, 2021

SELL
$3.95 - $5.42 $853 - $1,170
-216 Reduced 0.26%
82,574 $377,000
Q3 2020

Nov 13, 2020

SELL
$3.54 - $5.27 $15,395 - $22,919
-4,349 Reduced 4.99%
82,790 $322,000
Q2 2020

Aug 14, 2020

SELL
$2.87 - $5.46 $6,259 - $11,908
-2,181 Reduced 2.44%
87,139 $415,000
Q1 2020

May 14, 2020

BUY
$2.46 - $5.35 $94,527 - $205,579
38,426 Added 75.5%
89,320 $310,000
Q4 2019

Feb 13, 2020

BUY
$2.65 - $5.56 $23,158 - $48,588
8,739 Added 20.73%
50,894 $245,000
Q3 2019

Nov 13, 2019

BUY
$2.29 - $7.1 $10,185 - $31,580
4,448 Added 11.8%
42,155 $122,000
Q2 2019

Aug 14, 2019

BUY
$6.44 - $14.29 $18,135 - $40,240
2,816 Added 8.07%
37,707 $270,000
Q1 2019

May 15, 2019

BUY
$11.87 - $14.84 $4,581 - $5,728
386 Added 1.12%
34,891 $495,000
Q4 2018

Feb 15, 2019

BUY
$13.09 - $21.49 $23,692 - $38,896
1,810 Added 5.54%
34,505 $467,000
Q3 2018

Nov 20, 2018

BUY
$16.4 - $24.27 $91,774 - $135,814
5,596 Added 20.65%
32,695 $726,000
Q2 2018

Aug 10, 2018

BUY
$13.95 - $20.2 $378,031 - $547,399
27,099 New
27,099 $445,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.24B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.